He Transitioned, Regretted It, and Faced the Truth About Autogynephilia - Ray (#9)
17 April 2025
With Ray
Global
Ray spent eight years living as a transwoman before detransitioning. Speaking with the Beyond Gender hosts, he reflects on autogynephilia as the underlying driver of his transition, the role online communities played in shaping his identity, and the health consequences of long-term hormone therapy. His account carries particular weight for Irish gender medicine: he describes body dysphoria appearing only after he identified as trans, not before — a sequence the standard clinical pathway is poorly designed to detect or address.
Ray spent eight years living as a transwoman before concluding that transition had not resolved the underlying reality of his psychology. In this episode of Beyond Gender, he traces his experience from childhood cross-dressing through medical transition and ultimately to detransition, speaking with a candour that is rare in public conversations about gender. His account is framed around his own understanding of autogynephilia — a concept he finds genuinely explanatory rather than stigmatising — and the years it took him to reach that understanding. Autogynephilia, as described by Canadian sexologist Ray Blanchard in research dating from the 1980s and 1990s, refers to a male's sexual arousal at the thought or image of himself as female. It remains contested in gender medicine: clinicians and researchers who accept Blanchard's typology argue it explains a significant subset of adult male transitions, while advocates of gender-identity ideology have largely sought to discredit the framework. Ray discusses autogynephilia not as a stigma but as a model that finally made sense of his own history — one that began with fixation on women's clothing in childhood and moved, over decades, through shame, secrecy and reinforcement from online communities. One of the episode's most clinically significant moments is Ray's account of when his body dysphoria emerged. He describes it appearing after he had already identified as transgender — not before. This ordering is important. The gender-affirming care model, which is built around the assumption that pre-existing dysphoria drives and justifies transition, is not designed to distinguish between distress that precedes an identity and distress that follows from it. Ray also identifies the Caitlyn Jenner interview and online trans communities as catalysts that crystallised a trans identity from what had previously been a paraphilia he managed privately — illustrating the well-documented pathway from online exposure to identity consolidation that researchers have begun to examine more rigorously. Medical transition brought physical and emotional changes that Ray reflects on honestly, including health complications arising from hormone replacement therapy that were among the factors prompting his decision to step back. He describes the practical and psychological process of returning to life as a man, his experience working in the technology sector as a transwoman, and the philosophical frameworks that helped him navigate nearly a decade of living in a way he ultimately found unsustainable. His discussion of managing autogynephilia after detransition — without suppression, without transition — is one of the more substantive treatments of the subject available in a public forum. From an Irish perspective, several dimensions of Ray's account matter directly. Ireland's Gender Recognition Act 2015 was among the first pieces of legislation in Europe to introduce self-declaration for legal gender change, requiring no medical assessment. The HSE operates the National Gender Service, which provides evaluation and referral for gender dysphoria, but Ireland has no dedicated detransition care pathway. Those who regret transition or wish to reverse aspects of medical intervention must navigate a system that was not built with them in mind. Ray's testimony — measured, self-aware and grounded in years of lived experience — is precisely the kind of evidence that should inform how Irish clinicians, policymakers and the HSE approach assessment, informed consent and post-transition follow-up.
